Ivax Corporation
Patent Applications and Registrations
Patent applications and USPTO patent grants for Ivax Corporation.The latest application filed is for "cladribine formulations for improved oral and transmucosal delivery".
- Ivax Corporation - Miami FL
- IVAX CORPORATION - 4400 Biscayne Boulevard Miami FL
Trademarks
| Patent | Date |
|---|---|
| Solid state forms of 5-azacytidine and processes for preparation thereof Grant 7,759,481 - Gavenda , et al. July 20, 2 | 2010-07-20 |
| Medicament dispensing device with a display indicative of the state of an internal medicament reservoir Grant 7,331,340 - Barney February 19, 2 | 2008-02-19 |
| Cladribine formulations for improved oral and transmucosal delivery App 20070065492 - Bodor; Nicholas S. | 2007-03-22 |
| Dose metering system for medicament inhaler Grant 6,718,972 - O'Leary April 13, 2 | 2004-04-13 |
| Pre-metered dose magazine for breath-actuated dry powder inhaler Grant 6,655,381 - Keane , et al. December 2, 2 | 2003-12-02 |
| NCAGE Code | 32WY0 | IVAX CORPORATION |
| NCAGE Code | 95510 | IVAX CORP |
| CAGE Code | 32WY0 | IVAX CORPORATION |
| CAGE Code | 95510 | IVAX CORP |
| SEC | 0000772197 | IVAX CORP |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 